Renaud Bonnet > Jones Day > Paris, France > Lawyer Profile

Françoise Labrousse and Renaud Bonnet co-lead the team at Jones Day, which often advises on collaboration and investment agreements. Labrousse is recommended for her deep knowledge of administrative disputes, while private equity specialist Bonnet often assists with M&A, IPOs, and the full spectrum of financing issues. Described by clients as ‘one of the foremost patent litigators in France’, Thomas Bouvet is well equipped to advise on SPCs, standard essential patents, and patent enforcement actions relating to medical devices and pharma products.

Lauded by one client for its ‘unique knowledge of the venture/growth capital sector’, the Jones Day practice group is a strong choice for the gamut of mandates, including seed and late-stage financing. The group, which is routinely instructed by startups and international corporations alike, is jointly directed by Renaud Bonnet and Charles Gavoty (‘very good listeners, excellent technicians, perfect knowledge of market practices’); along with private equity, M&A and capital markets specialists Jean-Gabriel Griboul, Anne Kerneur and Geoffroy Pineau-Valencienne. As of early 2024, ‘standout partner’ Alexandre Wibaux splits his time between New York and Paris.

Jones Day is a reference for French and US ECM work in the biotech and tech sectors, notably on the Euronext Growth segment, through the Parisian team’s combined US and French ECM expertise. The firm assists many startups and biotech companies with their ECM needs including share capital increase, IPOs and private placement transactions. The team is co-headed by US expert Linda Hesse , Florent Bouyer and Renaud Bonnet. Charles Gavoty  and counsel Seth Engel  also contributes.